0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Comments, Opinions, and Brief Case Reports | 
Alfred Soffer
Arch Intern Med. 2004;164(11):1242. doi:10.1001/archinte.164.11.1242.

Editor's Correspondence | 
Giovanni Passalacqua, MD; Carlo Lombardi, MD
Arch Intern Med. 2004;164(1):106. doi:10.1001/archinte.164.1.106-b.

Comments, Opinions, and Brief Case Reports | 
Geoffrey C. Wall, PharmD, BCPS; Dori Bigner, MD, MS; Steven Craig, MD
Arch Intern Med. 2003;163(1):116-117. doi:10.1001/archinte.163.1.116.

Editor's Correspondence | 
Francesco Drago; Alfredo Rebora
Arch Intern Med. 2002;162(7):843. doi:.

Clinical Observation | 
Mar Masiá, MD; Félix Gutiérrez, MD; Araceli Jimeno, MD; et al.
Arch Intern Med. 2002;162(4):474-476. doi:10.1001/archinte.162.4.474.

Comments, Opinions, and Brief Case Reports | 
Roberto Manfredini, MD; Chiara Delli Gatti, MD; Olga la Cecilia, MD; et al.
Arch Intern Med. 2001;161(16):2043-2044. doi:.

Comments, Opinions, and Brief Case Reports | 
Rodolfo Carrillo-Jimenez, MD; Matthew Zogby, MD; Thomas L. Treadwell, MD
Arch Intern Med. 2001;161(12):1556. doi:.

Editor's Correspondence | 
Vladimir Vuksan, PhD; John L. Sievenpiper, MSc
Arch Intern Med. 2000;160(21):3330-3331. doi:.

Editor's Correspondence | 
Marc R. Matthews, MD; Daniel M. Caruso, MD; Bradley J. Phillips, MD; et al.
Arch Intern Med. 1999;159(18):2225. doi:.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA Dermatology
Case Report/Case Series  | 
Subcutaneous Veltuzumab, a Humanized Anti-CD20 Antibody, in the Treatment of Refractory Pemphigus Vulgaris
Christoph T. Ellebrecht, MD; Eun J. Choi, BS; David M. Allman, PhD; et al.
JAMA Dermatology
The Cutting Edge  | 
Epidermal Grafting Using a Novel Suction Blister–Harvesting System for the Treatment of Pyoderma Gangrenosum
Nicholas A. Richmond, MD; Sonia A. Lamel, MD; Liza R. Braun, MD; et al.
JAMA Dermatology
Case Report/Case Series  | 
High Anti–Desmoglein 3 Antibody ELISA Index and Negative Indirect Immunofluorescence Result in a Patient With Pemphigus Vulgaris in Remission:  Evaluation of the Antibody Profile by Newly Developed Methods
Tomoko Nakahara, MD; Atsushi Takagi, MD, PhD; Jun Yamagami, MD, PhD; et al.
JAMA
JAMA Clinical Challenge  | 
Recurrent Erythema Multiforme
Jarad Levin, MD; Timothy Hofstra, MD